Clinically effective CK-MB reporting
Authors:
Open Access
- 1 January 2010
- journal article
- view point
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 56 (3) , 226-228
Abstract
The clinical utility of measuring the Muscle Brain (MB) isoenzyme of creatine kinase (CK) in the diagnosis of myocardial injury is well established. CK/CK-MB measurement in combination or CK-MB alone is widely used and reporting the results of CK-MB in absolute unit is the common current practice. CK-MB is widely measured by "Immunoinhibition" in India, which gives falsely elevated CK-MB results in the following circumstances: Central nervous system damage, childbirth, macro CK-immunoglobulin complex, in patients with carcinoma of various organs, such as prostate carcinoma and other adenocarcinomas. But, reporting %CK-MB rather than the absolute CK-MB results assists in detection of macroCK (or CK variants), associated proliferative and autoimmune pathologies and their prognosis.Keywords
This publication has 15 references indexed in Scilit:
- Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromesPostgraduate Medical Journal, 2008
- Competing risks of mortality with marathons: retrospective analysisBMJ, 2007
- Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteriaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2006
- Biomarkers of Cardiac Injury: An UpdateAngiology, 2005
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Creatine Kinase, Isoenzymes, and Variants1998
- Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical dataClinical Chemistry, 1994
- Creatine Kinase BB Isoenzyme in CSF in Neurologic DiseasesArchives of Neurology, 1983
- Macro creatine kinase types 1 and 2: clinical significance in neonates and children as compared with adults.Clinical Chemistry, 1983
- Creatine Kinase Isoenzymes in High-Risk InfantsPediatric Research, 1980